Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1132393

registered interest
date	17/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genito-urinary Medicine: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to allocate additional funding for the provision of sexual health services in the next four years.
tabling member constituency	Bermondsey and Old Southwark
tabling member printed	Neil Coyle
uin	265528
answer	answer is ministerial correction date of answer 25/06/2019 answer text <p>The Government provides funding to local authorities for their public health responsibilities, including sexual health services, through a public health grant. It is for individual local authorities to decide their spending priorities based on an assessment of local need, including the need for sexual health services taking account of their statutory duties. They are required by regulations to provide services for sexually transmitted infection testing and treatment and contraception.</p><p>Future funding for local authorities’ public health responsibilities will be determined in the next spending review.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 25/06/2019 16:46:30 answering member 4455 label Biography information for Seema Kennedy
tabling member	4368 label Biography information for Neil Coyle

1132403

registered interest
date	17/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what contingency plans his Department has put in place in the event that Vertex declines NHS England’s latest offer for the supply of Orkambi.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	265417
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>NHS England is leading the negotiations with Vertex and has made a revised and improved offer to Vertex that would provide immediate funding for Orkambi, and Symkevi in advance of assessment by the National Institute for Health and Care Excellence (NICE), and expanded access to Kalydeco which is already funded on the National Health Service for certain patients.</p><p>The Government fully supports NICE and NHS England in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to urge Vertex to accept NHS England’s generous offer, but we will explore other options to ensure patients can access treatments as soon as possible.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 265418 question first answered 20/06/2019 09:33:36 answering member 4455 label Biography information for Seema Kennedy
tabling member	298 label Biography information for Steve McCabe

1132404

registered interest
date	17/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lumacaftor/ivacaftor: Clinical Trials
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of launching a large scale clinical trial of the generic version of Orkambi.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	265418
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>NHS England is leading the negotiations with Vertex and has made a revised and improved offer to Vertex that would provide immediate funding for Orkambi, and Symkevi in advance of assessment by the National Institute for Health and Care Excellence (NICE), and expanded access to Kalydeco which is already funded on the National Health Service for certain patients.</p><p>The Government fully supports NICE and NHS England in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to urge Vertex to accept NHS England’s generous offer, but we will explore other options to ensure patients can access treatments as soon as possible.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 265417 question first answered 20/06/2019 09:33:36 answering member 4455 label Biography information for Seema Kennedy
tabling member	298 label Biography information for Steve McCabe

1132420

registered interest
date	17/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Digital Technology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the NHS has access to faster digital technology systems to enable practices to be run more efficiently.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	265459
answer	answer is ministerial correction date of answer 25/06/2019 answer text <p>We are committed to ensuring that all practices have access to faster digital technology systems to enable to high quality, effective healthcare services that are responsive to all patients’ needs.</p><p>We have rolled out National Health Service WiFi across 96.8% of general practitioner (GP) practices, benefiting the care of an estimated 57.8 million patients. The new Health and Social Care Network (HSCN) arrangements are enabling clinical commissioning groups (CCGs) to obtain faster data network connections for GPs and all GP practices are expected to have migrated from their legacy connectivity to new HSCN services by the end of 2020.</p><p>The fourth edition of the GP IT Operating Model requires CCGs to adopt appropriately-sized HSCN connectivity capable of supporting their current and future GP business needs and states they should upgrade any existing copper-based asymmetric digital subscriber line (ADSL) connections providing primary connectivity to practice premises to fibre-based connections such as Fibre to the Cabinet (FTTC) or Fibre to the Premise (FTTP) as a minimum.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 25/06/2019 16:00:29 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1436 label Biography information for Paul Farrelly

1132424

registered interest
date	17/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Skin Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the number of cases of melanoma.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	265456
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>On 16 June 2014, a local pilot campaign launched in Devon, Cornwall and Somerset to raise awareness of the signs of skin cancer. It encouraged people to tell their doctor if they noticed any unusual or persistent changes to their skin. It ran until 27 July 2014 and included adverts in the press and on local radio, as well as some direct mail to the target group.</p><p> </p><p>Skin Cancer awareness month is an annual awareness campaign that takes place every May. The campaign aims to raise awareness of the dangers of unprotected sun exposure and educate the public about the ways to help prevent skin cancer.</p><p>The Sunbeds (Regulation) Act 2010 came into force in April 2011 in England and Wales to prohibit under-18s from using sunbeds.</p><p> </p><p>Public Health England (PHE) contributed to the revision of the World Health Organization publication “Artificial tanning devices - Public health interventions to manage sunbeds”, which was published in 2017. PHE advises that sunbeds emit ultraviolet radiation, which can cause tanning and sunburn.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 20/06/2019 14:14:40 answering member 4455 label Biography information for Seema Kennedy
tabling member	1409 label Biography information for Mr Gregory Campbell

1132427

registered interest
date	17/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genomics: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many patients have received whole genome sequencing through the NHS; and how many of those patients had a type of blood cancer.
tabling member constituency	Totnes
tabling member printed	Dr Sarah Wollaston
uin	265508
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>As part of the NHS Long Term Plan, the National Health Service has committed to sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and the evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 265509 265510 question first answered 20/06/2019 15:34:08 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4073 label Biography information for Dr Sarah Wollaston

1132428

registered interest
date	17/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genomics: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many patients he estimates will benefit from whole genome sequencing in (a) 2019 and (b) each of the next five years.
tabling member constituency	Totnes
tabling member printed	Dr Sarah Wollaston
uin	265509
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>As part of the NHS Long Term Plan, the National Health Service has committed to sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and the evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 265508 265510 question first answered 20/06/2019 15:34:08 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4073 label Biography information for Dr Sarah Wollaston

1132429

registered interest
date	17/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genomics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when the NHS Genomic Medicine Service will begin performing whole genome sequencing.
tabling member constituency	Totnes
tabling member printed	Dr Sarah Wollaston
uin	265510
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>As part of the NHS Long Term Plan, the National Health Service has committed to sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and the evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 265508 265509 question first answered 20/06/2019 15:34:08 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4073 label Biography information for Dr Sarah Wollaston

1132430

registered interest
date	17/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pathology: Vacancies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the level of vacancy is in histopathology departments.
tabling member constituency	Totnes
tabling member printed	Dr Sarah Wollaston
uin	265511
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>NHS Improvement publishes vacancy data for three staff groups; doctors, nurses and ‘other staff’. These vacancy statistics are published for England and at the regional level of North, Midlands and East, London and South.</p><p>They do not specifically produce vacancy data for histopathology departments or any vacancy data for each National Health Service hospital or trust.</p><p>NHS Digital published the latest NHS Improvement vacancy data which can be found in the following link:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-vacancies-survey/february-2015---march-2019-provisional-experimental-statistics" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-vacancies-survey/february-2015---march-2019-provisional-experimental-statistics</a></p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 20/06/2019 13:12:02 answering member 1585 label Biography information for Stephen Hammond
tabling member	4073 label Biography information for Dr Sarah Wollaston

1132434

registered interest
date	17/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Eating Disorders
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effectiveness of funding allocated to (a) NHS Trusts and (b) Clinical Commissioning Groups for eating disorder treatments; and what steps he is taking to ensure the effectiveness of the use of that funding by (i) NHS Trusts and (ii) Clinical Commissioning Groups.
tabling member constituency	Filton and Bradley Stoke
tabling member printed	Jack Lopresti
uin	265499
answer	answer is ministerial correction date of answer 25/06/2019 answer text <p>The NHS Long Term Plan committed at least a further £2.3 billion a year to mental health services by 2023/24. This investment will transform and expand services for people with mental health conditions, including eating disorders, building on our current targets.</p><p>The mental health investment standard (MHIS) requires clinical commissioning groups (CCGs) to increase the amount spent on mental health by at least as much as their overall budget. In 2018/19 it is expected all CCGs will achieve the MHIS level of investment.</p><p>We have set up the first waiting times standard to improve access to eating disorder services for children and young people with the aim that 95% of children with an eating disorder will receive treatment within one week for urgent cases and within four weeks for routine cases by 2020/21. The latest available waiting times figures against this standard, indicate that NHS England is on track to meet it by 2020/21. Data from the quarter 4 January to March 2019 shows 80.6% of all patients started urgent treatment within one week and 82.4% of patients started routine treatment within four weeks.</p><p>The NHS Long Term Plan commits to testing four-week waiting times for adult and older adult community mental health teams, in selected local areas. The exact scope and timelines of these pilots are yet to be finalised.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 25/06/2019 15:59:21 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	3989 label Biography information for Jack Lopresti